Clinical Trials Browser

Recruiting × OTHER × Pharmacogenomic Variants × Clear all

NCT03582124 2026-02-10

Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery

Phase 1/2 Recruiting

Lung Neoplasms